Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

Research/Development

9 posts
RRoche
Roche Stops Work on Obesity Drug Emugrobart After Trial Data
Read More

Roche Stops Work on Obesity Drug Emugrobart After Trial Data

  • 2026-11-02
Roche Holding ROP -0.31%decrease; down pointing triangle said it stopped work on one of its obesity-drug candidates, after…
NNovartis
Novartis Stock Drops After Another Trial Setback
Read More

Novartis Stock Drops After Another Trial Setback

  • 2026-10-07
Novartis NOVN -1.46%decrease; down pointing triangle shares dropped as much as 10% after the drugmaker said an experimental…
RRoche
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
Read More

Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

  • 2026-10-04
Roche ROP -1.72%decrease; down pointing triangle Holding said an obesity drug candidate met the main objectives of a…
NNovartis
Novartis Stock Prices Fall After Cardiovascular Drug Fails in Trial
Read More

Novartis Stock Prices Fall After Cardiovascular Drug Fails in Trial

  • 2026-09-23
Novartis NOVN 2.84%increase; up pointing triangle shares fell after the Swiss drugmaker said an experimental medicine failed to…
NNovartis
Novartis Stock Prices Rise After Positive Multiple Sclerosis Drug Trial Results
Read More

Novartis Stock Prices Rise After Positive Multiple Sclerosis Drug Trial Results

  • 2026-09-14
Novartis NOVN -0.09%decrease; down pointing triangle shares rose after the drugmaker reported positive results from two late-stage trials…
RRoche
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Read More

Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial

  • 2026-08-13
Roche Holding ROP 1.21%increase; up pointing triangle said a drug candidate showed better potential than existing therapies in…
RRoche
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study
Read More

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

  • 2026-05-30
Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
NNovartis
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Read More

Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

  • 2026-05-19
Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
NNovartis
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Read More

Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

  • 2026-04-03
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…
Switzerland
www.europesays.com